Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-12-044924
Filing Date
2012-08-10
Accepted
2012-08-10 15:32:16
Documents
1
Period of Report
2012-08-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd352831.html 3  
1 FORM 3 rrd352831.xml 3 7977
  Complete submission text file 0001181431-12-044924.txt   9362
Mailing Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Issuer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address KALOBIOS PHARMACEUTICALS, INC. 260 EAST GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address
Yarranton Geoffrey Thomas (Reporting) CIK: 0001555737 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-54735 | Film No.: 121024454